Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Monday, up 15.74% from the previous trading day, before settling in for the closing price of $0.40. Over the past 52 weeks, APLT has traded in a range of $0.29-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -19.09% over the past five years. While this was happening, its average annual earnings per share was recorded 9.39%. With a float of $111.03 million, this company’s outstanding shares have now reached $137.23 million.
Let’s look at the performance matrix of the company that is accounted for 35 employees. In terms of profitability, gross margin is 47.15%, operating margin of -22872.37%, and the pretax margin is -23163.16%.
Applied Therapeutics Inc (APLT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 21.57%, while institutional ownership is 75.53%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 9.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.05% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 3.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 142.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 1.67 million, a negative change from its year-to-date volume of 3.12 million. As of the previous 9 days, the stock’s Stochastic %D was 48.72%. Additionally, its Average True Range was 0.05.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 19.60%, which indicates a significant decrease from 79.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.52% in the past 14 days, which was lower than the 99.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4448, while its 200-day Moving Average is $3.6888. Nevertheless, the first resistance level for the watch stands at $0.4786 in the near term. At $0.4945, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5241. If the price goes on to break the first support level at $0.4331, it is likely to go to the next support level at $0.4035. The third support level lies at $0.3876 if the price breaches the second support level.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 65.49 million has total of 141,576K Shares Outstanding. Its annual sales at the moment are 460 K in contrast with the sum of -105,620 K annual income. Company’s last quarter sales were recorded 120 K and last quarter income was -68,590 K.
